1. Circulating-tumor DNA Assessment in
Diffuse Large B-cell Lymphoma to Determine Up-front Stem Cell Transplantation:
A Pilot Study.
Kim J, LE TM, Lee D, Nguyen HDT, Cho HJ,
Sohn SK, Kim JG, Jeong SY, Ham JY, Jeong JY, Han HS, Moon JH, Baek DW.
In Vivo. 2024 Jan-Feb;38(1):372-379. doi:
10.21873/invivo.13448.
2. Real-world data of long-term survival in
patients with T-cell lymphoma who underwent stem cell transplantation.
Baek DW,
Moon JH, Lee JH, Kang KW, Lee HS, Eom HS, Lee E, Lee JH, Lee JO, Park SK, Kim
SJ, Yoo KH, Yoon SS, Koh Y, Kang HJ, Won JH, Lyu CJ, Hahn SM, Lee JH, Park JS,
Jo JC, Mun YC, Yang DH, Song GY, Lim SN, Sohn SK; Korean Society of Blood and
Marrow Transplantation.
Blood Cancer J. 2023 Jun 26;13(1):95. doi:
10.1038/s41408-023-00868-w.
3. Rituximab plus multiagent chemotherapy
for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective
phase II study.
Baek DW,
Park HS, Sohn SK, Kim DY, Kim I, Ahn JS, Do YR, Lee SR, Eom HS, Lee WS, Kim SH,
Lee HS, Lee YJ, Moon JH, Lee JH; Adult Acute Lymphoblastic Leukemia Working
Party, the Korean Society of Hematology.
Korean J Intern Med. 2023
Sep;38(5):734-746. doi: 10.3904/kjim.2022.401. Epub 2023 Jun 20.
4. Predictive role of absolute lymphocyte
count in daratumumab-treated patients with relapsed/ refractory multiple
myeloma.
Cho HJ, Jo JC, Lee YJ, Lee MW, Kim DY, Shin
HJ, Im SN, Lee JH, Bae SH, Do YR, Lee WS, Kim MK, Jung J, Lee JM, Kim JH, Baek
DW, Sohn SK, Moon JH.
Korean J Intern Med. 2023
Mar;38(2):238-247. doi: 10.3904/kjim.2022.183. Epub 2023 Jan 26.
5. Two cases of extramedullary plasmacytoma
of the small intestine presenting with ileus: A case report.
Park KB, Kwon HJ, Jeong JY, Baek DW,
Cho SH, Seo AN.
Medicine (Baltimore). 2022 Oct
7;101(40):e30842. doi: 10.1097/MD.0000000000030842.
6. Reversible striatal hypermetabolism of
acquired chorea associated with polycythemia vera.
Hong CM, Yang SY, Cho M, Baek DW,
Ryu HS.
Acta Neurol Belg. 2023
Oct;123(5):1997-2000. doi: 10.1007/s13760-022-02058-0. Epub 2022 Aug 3.
7. Severe congenital neutropenia mimicking
chronic idiopathic neutropenia: a case report.
Kim J, Hwang S, Hwang N, Lee Y, Cho HJ,
Moon JH, Sohn SK, Baek DW.
J Yeungnam Med Sci. 2023 Jul;40(3):283-288.
doi: 10.12701/jyms.2022.00353. Epub 2022 Jul 28.
8. Results of Multicenter Phase II Study
With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic
GVHD.
Baek DW, Cho
HJ, Kim JH, Ahn JS, Kim HJ, Lim SN, Cheong JW, Kim SY, Lee HS, Won JH, Yhim HY,
Sohn SK, Moon JH.
Cell Transplant. 2022
Jan-Dec;31:9636897221113789. doi: 10.1177/09636897221113789.
9. Light and shade of ruxolitinib: positive
role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in
patients with myelofibrosis.
Baek DW, Cho
HJ, Lee JM, Kim J, Moon JH, Sohn SK.
Expert Rev Hematol. 2022 Jul;15(7):573-581.
doi: 10.1080/17474086.2022.2088499. Epub 2022 Jun 14.
10. Clinical Implication of KRAS Mutation
Variants in Patients With Resected Colon Cancer.
Baek JH, Kim J, Baek DW, Chang E,
Kim HJ, Park SY, Park JS, Choi GS, Kang BW, Kim JG.
Cancer Diagn Progn. 2022 Jan 3;2(1):78-83.
doi: 10.21873/cdp.10079. eCollection 2022 Jan-Feb.
11. Clinical impact of spine magnetic
resonance imaging as a valuable prognostic tool for patients with multiple
myeloma: a retrospective study.
Lee JM, Cho HJ, Moon JH, Sohn SK, Park B, Baek
DW.
J Yeungnam Med Sci. 2022 Oct;39(4):300-308.
doi: 10.12701/jyms.2021.01648. Epub 2022 Mar 23.
12. Clinical Impact of Prognostic Nutrition
Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated
Nivolumab Monotherapy.
Lee J, Choi SH, Baek JH, Baek DW,
Kim JG, Kang BW.
Chonnam Med J. 2022 Jan;58(1):24-28. doi:
10.4068/cmj.2022.58.1.24. Epub 2022 Jan 25.
13. Clinical implication of adjuvant
chemotherapy according to mismatch repair status in patients with
intermediate-risk stage II colon cancer: a retrospective study.
Kang BW, Baek DW, Chang E, Kim HJ,
Park SY, Park JS, Choi GS, Baek JH, Kim JG.
J Yeungnam Med Sci. 2022 Apr;39(2):141-149.
doi: 10.12701/yujm.2021.01571. Epub 2021 Dec 22.
14. Patients presenting high fever with
lymphadenopathy after COVID-19 vaccination were diagnosed with hemophagocytic
lymphohistiocytosis.
Baek DW,
Hwang S, Kim J, Lee JM, Cho HJ, Moon JH, Hwang N, Jeong JY, Lee SW, Sohn SK.
Infect Dis (Lond). 2022 Apr;54(4):303-307. doi:
10.1080/23744235.2021.2010801. Epub 2021 Dec 2.
15. Favorable Long-Term Outcomes with
Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients
with a Positive Result On 18F-FDG PET/CT at Baseline.
Cho HJ, Baek DW, Kim JH, Lee J, Chung
YK, Jung SH, Song GY, Ahn SY, Ahn JS, Yang DH, Lee JJ, Kim HJ, Hong CM, Jeong
SY, Min JJ, Sohn SK, Moon JH.
Clin Lymphoma Myeloma Leuk. 2022
Feb;22(2):113-120. doi: 10.1016/j.clml.2021.08.012. Epub 2021 Aug 31.
16. Pediatric-inspired regimen with late
intensification and increased dose of L-asparaginase for adult acute
lymphoblastic leukemia: the KALLA 1406/1407 study.
Baek DW, Kim
DY, Sohn SK, Koh Y, Jung SH, Yhim HY, Choi Y, Moon JH.
Korean J Intern Med. 2021
Nov;36(6):1471-1485. doi: 10.3904/kjim.2021.028. Epub 2021 Sep 24.
17. Keeping a balance in chronic
lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated
adverse events and their management based on drug interactions.
Cho HJ, Baek DW, Kim J, Lee JM, Moon
JH, Sohn SK.
Expert Rev Hematol. 2021 Sep;14(9):819-830.
doi: 10.1080/17474086.2021.1967139. Epub 2021 Aug 22.
18. Successful Treatment with High-Dose
Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with
Metastatic Germ Cell Tumor.
Lee JM, Kang BW, Han MH, Baek DW.
Case Rep Oncol. 2021 Jun 24;14(2):998-1003.
doi: 10.1159/000516755. eCollection 2021 May-Aug.
19. Therapeutic strategies, including
allogeneic stem cell transplantation, to overcome relapsed/refractory adult
T-cell acute lymphoblastic leukemia.
Baek DW, Lee
JM, Kim J, Cho HJ, Moon JH, Sohn SK.
Expert Rev Hematol. 2021 Aug;14(8):765-775.
doi: 10.1080/17474086.2021.1960817. Epub 2021 Aug 9.
20. Clinical Impact of Postoperative
Vitamin D Deficiency on the Recurrence of Colon Cancer After Curative Surgical
Resection.
Kim J, Baek DW, Baek JH, Kang BW,
Song SH, Kim HJ, Park SY, Park JS, Choi GS, Kim JG.
Anticancer Res. 2021 Jul;41(7):3683-3688.
doi: 10.21873/anticanres.15159.
21. Clinical impact of cell-free serum
Epstein-Barr virus status in patients with newly diagnosed malignant lymphoma.
Baek DW, Lee
JM, Kim J, Cho HJ, Sohn SK, Ham JY, Chang SH, Moon JH, Yang DH.
Blood Res. 2021 Jun 30;56(2):65-71. doi:
10.5045/br.2021.2021028.
22. Pembrolizumab-related autoimmune
hemolytic anemia in a patient with metastatic lung adenocarcinoma: a case
report.
Baek DW,
Chae YS.
Yeungnam Univ J Med. 2021
Oct;38(4):366-370. doi: 10.12701/yujm.2021.00899. Epub 2021 Mar 23.
23. Initial experience of preoperative
short-course radiotherapy followed by oxaliplatin-based consolidation
chemotherapy for locally advanced rectal cancer.
Song SH, Park JS, Kang MK, Choi GS, Park
SY, Kim HJ, Kim JG, Kang BW, Baek JH, Baek DW, Kim JC, Park SH, Cho SH,
Seo AN.
Int J Colorectal Dis. 2021
Jun;36(6):1279-1286. doi: 10.1007/s00384-021-03875-0. Epub 2021 Feb 6.
24. Predictive Value of Circulating miRNAs
in Lymph Node Metastasis for Colon Cancer.
Lee IH, Kim G, Kwak SG, Baek DW,
Kang BW, Kim HJ, Park SY, Park JS, Choi GS, Hur K, Kim JG.
Genes (Basel). 2021 Jan 27;12(2):176. doi:
10.3390/genes12020176.
25. Prognostic impact of 18F-FDG PET/CT in
patients with multiple myeloma presenting with renal impairment.
Ahn SY, Park HK, Moon JH, Baek DW,
Cho HJ, Sohn SK, Kang SR, Min JJ, Bom HS, Hong CM, Jeong SY, Song GY, Yang DH,
Ahn JS, Kim HJ, Jung SH, Lee JJ.
Int J Hematol. 2021 May;113(5):668-674.
doi: 10.1007/s12185-021-03079-w. Epub 2021 Jan 21.
26. Open-label, single arm, multicenter
phase II study of VIDL induction chemotherapy followed by upfront autologous
stem cell transplantation in patients with advanced stage extranodal NK/T-cell
lymphoma.
Song GY, Yoon DH, Suh C, Moon JH, Baek
DW, Kim JS, Lee GW, Yi JH, Park Y, Jung KS, Kim SJ, Yang DH, Kim WS.
Bone Marrow Transplant. 2021
May;56(5):1205-1208. doi: 10.1038/s41409-020-01160-2. Epub 2020 Dec 4.
27. The Therapeutic Effect of
Cyclin-Dependent Kinase 4/6 Inhibitor on Relapsed Ectopic Male Breast Cancer.
Baek DW,
Park JY, Lee SJ, Chae YS.
J Breast Cancer. 2020 Oct;23(5):560-566.
doi: 10.4048/jbc.2020.23.e39.
28. Hypomethylating agent-based
post-transplant strategies to maximize the outcome of high-risk acute myeloid
leukemia after allogeneic stem cell transplantation.
Baek DW, Kim
J, Cho HJ, Moon JH, Sohn SK.
Expert Rev Hematol. 2020 Sep;13(9):959-969.
doi: 10.1080/17474086.2020.1804355. Epub 2020 Aug 14.
29. Quantitative Assessment of Interim
PET/CT Could Have More Prognostic Relevance than Visual Assessment for
Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma.
Baek DW, Cho
HJ, Kim JH, Sohn SK, Song GY, Ahn SY, Jung SH, Ahn JS, Lee JJ, Kim HJ, Jeong
SY, Hong CM, Min JJ, Moon JH, Yang DH.
In Vivo. 2020 Jul-Aug;34(4):2127-2134. doi:
10.21873/invivo.12018.
30. Prognostic Impact of the Neoadjuvant
Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic
TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant
Chemoradiotherapy.
Baek JH, Baek DW, Kang BW, Kim HJ,
Park SY, Park JS, Choi GS, Kim JG.
In Vivo. 2020 Jul-Aug;34(4):1993-1999. doi:
10.21873/invivo.11997.
31. Apparent diffusion coefficient as a
valuable quantitative parameter for predicting clinical outcomes in patients
with newly diagnosed primary CNS lymphoma.
Baek DW, Cho
HJ, Bae JH, Sohn SK, Moon JH.
Blood Res. 2020 Jun 30;55(2):99-106. doi:
10.5045/br.2020.2020032.
32. COVID-19 transmission and blood
transfusion: A case report.
Cho HJ, Koo JW, Roh SK, Kim YK, Suh JS,
Moon JH, Sohn SK, Baek DW.
J Infect Public Health. 2020
Nov;13(11):1678-1679. doi: 10.1016/j.jiph.2020.05.001. Epub 2020 May 13.
33. Impressive effect of cisplatin
monotherapy on a patient with heavily pretreated triple-negative breast cancer
with poor performance.
Baek DW,
Park JY, Lee SJ, Chae YS.
Yeungnam Univ J Med. 2020
Jul;37(3):230-235. doi: 10.12701/yujm.2019.00423. Epub 2020 Jan 22.
34. Clinical Effects of Hypomethylating
Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received
DNA-Damaging Chemotherapy for Metastatic Breast Cancer.
Baek DW, Lee
SJ, Sohn SK, Moon JH, Chae YS.
J Breast Cancer. 2019 Dec;22(4):647-652.
doi: 10.4048/jbc.2019.22.e50.
35. High expression of microRNA-199a-5p is
associated with superior clinical outcomes in patients with locally advanced
rectal cancer.
Baek DW, Kim
G, Kang BW, Kim HJ, Park SY, Park JS, Choi GS, Kang MK, Hur K, Kim JG.
J Cancer Res Clin Oncol. 2020
Jan;146(1):105-115. doi: 10.1007/s00432-019-03099-4. Epub 2019 Nov 28.
36. Favorable long-term survival using
consolidation chemotherapy without allogeneic hematopoietic cell
transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD.
Baek DW, Lee
JM, Kim JH, Cho HJ, Ham JY, Suh JS, Sohn SK, Moon JH.
Blood Res. 2019 Sep;54(3):189-197. doi:
10.5045/br.2019.54.3.189. Epub 2019 Sep 25.
37. Prognostic Significance of
Clinicopathological and Molecular Features After Neoadjuvant Chemoradiotherapy
in Rectal Cancer Patients.
Cho HJ, Baek JH, Baek DW, Kang BW,
Lee SJ, Kim HJ, Park SY, Park JS, Choi GS, Kim JG.
In Vivo. 2019 Nov-Dec;33(6):1959-1965. doi:
10.21873/invivo.11691.
38. Novel Therapeutic Approaches for
Epstein-Barr Virus Associated Gastric Cancer.
Kang BW, Baek DW, Kang H, Baek JH,
Kim JG.
Anticancer Res. 2019 Aug;39(8):4003-4010.
doi: 10.21873/anticanres.13555.
39. Favorable Outcomes With Tumor Burden
Reduction Following Administration of Hypomethylating Agents Before Allogeneic
Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic
Syndrome.
Park S, Baek DW, Sohn SK, Ahn JS, Kim HJ,
Shin HJ, Chung JS, Lee SM, Lee WS, Lim SN, Lee YJ, Choi Y, Lee HS, Cho YY, Lee
GW, Moon JH.
Clin Lymphoma Myeloma Leuk. 2019
Jul;19(7):e367-e373. doi: 10.1016/j.clml.2019.03.016. Epub 2019 Apr 11.
40. Clinical Implications of Mismatch
Repair Status in Patients With High-risk Stage II Colon Cancer.
Baek DW,
Kang BW, Lee SJ, Kim HJ, Park SY, Park JS, Choi GS, Baek JH, Kim JG.
In Vivo. 2019 Mar-Apr;33(2):649-657. doi:
10.21873/invivo.11523.
41. The Predictive Value of Epstein-Barr
Virus-Positivity in Patients Undergoing Gastrectomy Followed by Adjuvant
Chemotherapy.
Baek DW,
Kang BW, Kim JG.
Chonnam Med J. 2018 Sep;54(3):173-177. doi:
10.4068/cmj.2018.54.3.173. Epub 2018 Sep 27.
42. Impact of Consolidation Cycles Before
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in
First Complete Remission.
Lee YJ, Baek DW, Ahn JS, Ahn SY,
Jung SH, Yang DH, Lee JJ, Kim HJ, Ham JY, Suh JS, Sohn SK, Moon JH.
Clin Lymphoma Myeloma Leuk. 2018
Dec;18(12):e529-e535. doi: 10.1016/j.clml.2018.08.010. Epub 2018 Aug 29.
43. Response to hypomethylating agents
improves long-term outcomes for lower-risk patients with myelodysplastic
syndrome in case-matched cohorts.
Baek DW, Lee
YJ, Kim H, Ahn SY, Ahn JS, Shin HJ, Lee WS, Lee SM, Song IC, Lee HS, Park SW,
Choi Y, Cho YY, Bae SH, Kim HJ, Sohn SK, Moon JH.
Ann Hematol. 2018 Dec;97(12):2309-2317.
doi: 10.1007/s00277-018-3458-7. Epub 2018 Aug 2.
44. Chemotherapy adherence is a favorable
prognostic factor for elderly patients with multiple myeloma who are treated
with a frontline bortezomib-containing regimen.
Cho HJ, Seo SK, Baek DW, Park SW,
Lee YJ, Sohn SK, Lee HS, Lee WS, Lee JH, Kim SH, Moon JH.
Yeungnam Univ J Med. 2018 Jun;35(1):76-83.
doi: 10.12701/yujm.2018.35.1.76. Epub 2018 Jun 30.
45. Elevated Neutrophil-to-Lymphocyte Ratio
Predicts Survival in Patients with Advanced Gastric Cancer Treated with
Trastuzumab Combination Chemotherapy.
Hwang GY, Baek DW, Cho HJ, Lee SJ,
Chae YS, Kang BW, Lee IH, Kim JG, Seo AN, Bae HI, Park KB, Park JY, Kwon OK,
Lee SS, Chung HY.
Anticancer Res. 2018 May;38(5):3151-3156.
doi: 10.21873/anticanres.12578.
46. Clinical Significance of p53 Protein
Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr
Virus-associated Gastric Cancer.
Baek DW,
Kang BW, Hwang S, Kim JG, Seo AN, Bae HI, Kwon OK, Lee SS, Chung HY, Yu W.
Chonnam Med J. 2017 May;53(2):140-146. doi:
10.4068/cmj.2017.53.2.140. Epub 2017 May 25.
47. New synergistic efficacy of combination
of romiplostim and steroid in refractory immune thrombocytopenia patients.
Yoon JS, Lee YJ, Baek DW, Park HY,
Park BE, Moon JH, Sohn SK.
Korean J Intern Med. 2018 Mar;33(2):435-437. doi: 10.3904/kjim.2015.252. Epub 2016 Mar 7.